Mineralys Therapeutics Competitors and Similar CompaniesClear all
Mineralys Therapeutics's competitors and similar companies include Elpiscience Biopharmaceuticals, Calypso Biotech, TScan Therapeutics and PaxMedica.
 Mineralys Therapeutics Mineralys Therapeutics (formerly known as Catalys SC1) is a biotechnology company focused on developing therapy treatments for hypertension. |  Elpiscience Biopharmaceuticals Elpiscience is a biopharmaceutical company specializing in cancer immunotherapy. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. |  PaxMedica PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS). | ||
Founding Date | Founding Date 2019 | Founding Date 2017 | Founding Date 2013 | Founding Date 2018 | Founding Date 2018 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Radnor, US HQ | Locations CN HQ Suzhou Shi, CN | Locations Plan-les-Ouates, CH HQ Amsterdam, NL | Locations Waltham, US HQ | Locations Tarrytown, US HQ |
Employees | Employees 7649% increase | Employees 33 | Employees 12 | Employees 7316% increase | Employees 2100% increase |
Valuation ($) | Valuation ($) 694.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 251.6 m | Valuation ($) 1.1 m |
Financial | |||||
Net income | Net income ($154.7m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($129.8m) (FY, 2025) | Net income ($18.3m) (FY, 2023) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 100m (over 6 years ago) | Latest funding round $ 22.8m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 158m | Total funding raised $ 155m | Total funding raised $ 26.1m | Total funding raised $ 137.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Elpiscience Biopharmaceuticals
HQ
CN
Employees
33
Elpiscience is a biopharmaceutical company specializing in cancer immunotherapy.
View company
Calypso Biotech
HQ
Plan-les-Ouates, CH
Employees
12
Calypso Biotech is an immunotherapy biotech company
View companyTScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View companyPaxMedica
HQ
Tarrytown, US
Employees
2
PaxMedica is a clinical-stage biopharmaceutical company developing anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, including Autism Spectrum Disorder (ASD) and Fragile X-associated tremor/ataxia (FXTAS).
View company